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1.!Introduction 
Rapid development in pulmonary drug delivery by inhalation 
aerosols in the past decade has led to novel invention of aerosol 
delivery devices and new formulation technologies. These 
devices have the capability of producing particles of defined 
characteristics for improved delivery. Extensive research in 
particle technology has advanced the ventricular inhaler device 
(VID) formulation by control of drug particle density, particle 
morphology, particle size, size distribution, particle injection 
process and system. VID is high advanced pressure Metered 
Dose Inhaler (pMDI). Additionally, spacers are often used 
between the inhaler outlet duct and the mouth cavity, which helps 
in mixing the concentrated dose with air to make it less dense. 
This helps those patients, who have severe problems with 
breathing. The key components of the VID device include 
propellants, formulation, metering dose, metering valve, actuator 
and cyclone separator comprises of small impeller, all play 
important roles in the formation of the spray, and in determining 
drug delivery to the lungs. There is large number of inventions in 
dry powder inhalers and VIDs, but not much concerns with the 
inhaler performance at a fundamental level. 
The design of a VID is vital to control the size range of drug 
particles emitted from the device. The drugs used inside the VID 
are Slabutamol, which is indicated for the treatment or prevention 
of bronchospasm in patients 4 years of age and older with 
reversible obstructive airway disease. It helps in treating various 
conditions including Exercise-Induced Bronchospasm 
Prevention, Asthma Attack, Bronchospasm and Chronic 
Obstructive Lung Disease. VID is designed to be used without 
the spacer. After the injection region within the VID, a small 
mixture region known as cyclone separator is created, which 
consists of an impeller (having three blades) and two air inlet 
ducts. The combination of air mixture with salbutamol helps the 
dosage to be fully mixed up. Thereafter the mixed dose is than 
ejected by the inhaler into patients’ mouth cavity. At present, 
there is little published literature that demonstrates how the 
design of inhaler affects the pressurized metered dose dispersion 
performance. Computational Fluid Dynamics (CFD) has found 
wide application in the study of pharmaceutical unit operations 
for drug delivery from the inhalers to the lungs. The dispersion 
and deposition of pharmaceutical aerosols in turbulent airflow is 
an important consideration when numerically investigating 
inhaler performance. 
Dumbar et al. [1-2] have carried out the first numerical 
simulations on pMDIs in investigating transport of the droplet 
and its formation during the actuation of the inhaler and 
thereafter, experimental investigations have been conducted to 
benchmark his results using laser diagnostic techniques. 
However, due to computationally intensive nature of the 
numerical simulations has prevented the sensitivity tests and 
hence the results have considered as preliminary. Versteeg et al. 
 
 
"#$%&'$!
 
 ()*+,)-*./)-0!1/2,)-0!/3!"/)4.*./)!$/).*/,.)5!-)4!&.-5)/6*.7!')5.)++,.)5!$-)-5+8+)*!
   
 
A B S T R A C T  
A Ventricular Inhaler Device (VID) is used as a quick-relief medication for treating wheezing and shortness of breath. VID uses Albuterol (a 
bronchodilator) to relax muscles and open airways. The flow distribution of Albuterol within the VID is the primary parameter that dictates the 
performance of the device. Poorly designed VIDs can cause accumulation of Albuterol in outlet section of the device, causing flow blockages, which lead 
to inefficient performance of the device and inappropriate drug delivery. In the present study, Computational Fluid Dynamics (CFD) based advanced 
techniques have been used in order to visualize the complex flow behavior within a conventional VID, with a purpose to enhance the performance of the 
device. It has been observed that the pressure coefficient within the injector and outlet duct remains constant, while it decreases in the cyclone separator. 
Thus, the inlet flow velocity has been seen to have dominating effect on the performance of the VID compared to the rotational velocity of the blades. It has 
been further noticed that as the flow rate of the drug increases, the efficiency of VID also decreases to a minimum value, after which it remains constant. 
Moreover, lower rotational speeds of the blades increase the efficiency of the device at higher drug flow rates. 
 
Keywords:   Computational Fluid Dynamics (CFD), Ventricular Inhaler Device (VID), pressure coefficient,  Reynolds Averages Navier-Stokes (RANS). 
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[3] have carried out numerical simulation using steady state 
airflow and aerosol plume to predict the behavior of flow within 
two pMDIs; experimental pMDIs and AstraZeneca Pulmicort 
pMDI. It has been found that the flow within both the inhalers is 
highly complex but similar. Multiple regions of recirculation 
within pMDI have been found with high levels of turbulence. 
Kleinstreuer et al. [4] have carried out investigation on the 
airflow, droplet transport and its deposition within pMDI and 
human upper airway model. The effect of spacer used between 
the pMDI and upper airway and nozzle diameter has been 
investigated. Chlorofluorocarbon (CFC) and hydrofluoroalkane-
134a (HFA) propellant aerosols have been numerically simulated 
using CFD solver to determine the effect of propellant properties 
and their deposition. The flow obtained within the inhaler body is 
highly complex with vortices generation at a steady flowrate of 
30l/min. The results obtained for both propellant aerosols are in 
good agreement with vivo and vitro studies conducted by Leach 
et al. [5] and Cheng et al. [6] respectively. Minor inconsistencies 
have been obtained due to assumptions considered in numerical 
simulations and physical processes including droplet 
coalescence, which is assumed negligible. Furthermore, it has 
been observed that better deposition performance has been found 
in HFA in comparison to CFC. This is due to differences in 
nozzle diameters considered. 
Kleinstreuer et al. [4] also considered the spacer used to 
quantify its effects on deposition rates for pMDIs with both 
propellant aerosols. The insertion of spacer between the pMDI 
and human upper airway model has shown sudden expansion in 
the volume with reduced flow velocity and higher droplet 
residence time and evaporation. The sudden reduction in droplet 
speed and size has reduced deposition in the oral cavity and 
hence the drug delivery to the lungs has highly increased. The 
performance of both the propellants CFC and HFA has improved 
using spacer with the pMDI. Leach and Colice [7] has carried out 
vivo by pilot study to assess lung deposition of HFA and CFC 
from a pMDI with and without add-on spacers and using varying 
breathhold times. The results carried out by Leach and Colice 
study are compared with Kleinstreuer et al. study. It has been 
observed that higher proportions of deposition are found in 
spacer in comparison to numerical simulations. The discrepancies 
obtained within both studies are due to change in nozzle 
diameters considered or formulation differences between vivo 
pMDIs of Leach and Colice and Kleinstreuer et al numerical 
simulations.  Furthermore, variations in the droplet size and 
velocities considered have significant impact on the deposition as 
well. However, the trend obtained depicts decreased 
oropharyngeal deposition with the use of spacer [4, 7]. Oliveria et 
al. [8] have carried out investigation on the development of a new 
Volumatic spacer design for better deposition performance. It has 
been found that design change to the spacer and valve used could 
reduce large areas of recirculation within the spacer. An 
optimized design of the spacer has been made by combining the 
best-performing body and valve geometries by considering a 
series of different combination of prototypes. It has been found 
that reduced recirculation and turbulence kinetic energy within 
pMDI reduces the droplet deposition inside the device and results 
better drug delivery to the patient lungs. 
Farina et al. [9] have invented a new approach of reducing 
deposition within pMDI and has considered various parameters 
that have high impact on the deposition. It has been investigated 
that every patient using pMDIs have different technique of using 
the inhaler such as shaking procedure, actuating force applied 
onto the inhaler and inhalation airflow entering the mouth cavity 
as every patient has different breathing patterns. This in results 
has impact on the amount of dosage entering the mouth cavity 
and then to lungs and also reduces the deposition performance. 
Therefore, an automated actuation system has been attached 
before the canister, which eject specific amount of droplets. 
Moreover, a sensor and actuator is attached at the exit duct of the 
inhaler. This consists of a cap on top of the exit, which when 
opens, gives a signal to the actuator to eject the droplets. 
Furthermore, a mixer consisting of blades is attached between the 
outlet duct and canister spray ejection region, which allows the 
droplets to get mixed with the air. The two ducts are also 
attached tangent to the mixer allows the ambient air to enter 
within the mixer. This process allows the droplets to get mixed 
with air and prepares enough dosage for the patient. As the 
mouth is attached, the dosage than enters the mouth cavity. This 
procedure reduces the impact of human abnormalities of using 
the pMDI and prevents from droplets deposition within the 
mouth cavity. 
The present study has been carried out to investigate the 
droplets flow behavior within the VID at different velocity rates 
at the inlet. Ansys Fluent has been used to carry out numerical 
simulations to solve discrete phase model of salbutamol droplets 
with air. The second section comprises of numerical procedures 
and boundary conditions used in this study. Section 3 comprises 
the detailed investigations of flow patterns at different mass flow 
rates of air entering the VID. Section 4 concludes the results 
obtained for the VID. 
2.!Numerical Modelling of VID 
The VID has been considered in the present study has been 
numerically modelled and analyzed to quantify the flow capacity 
of the inhaler. Detailed analyses of the complex flow behavior 
within the VID will be carried out. 
2.1.*Geometry and Spatial Discretization of the VID 
The geometry of the VID is shown in figure 1(a). For realistic 
results, the geometry has been modelled as realistically as 
possible. It has been shown in many research studies [10-17] that 
the primary reason behind the differences between the numerical 
and experimental results is non-matching geometry. The CID 
consists of two inlet ducts, which are tangent to the inhaler body. 
Furthermore, particles from the canister enter to the inhaler body 
via small pipe. Additionally, the inhaler body is a mixer region, 
which acts as cyclone separator consisting three blades, causes 
suction within the inhaler body. This causes the airflow entering 
the inhaler body. The VID, containing the impeller blades, has 
been spatially discretized using tetrahedral elements. Tetrahedral 
elements offer higher numerical diffusion compared to 
hexahedral elements, which is another spatial discretization 
technique. Tetrahedral elements are preferred in complex 
geometries and in the regions where flow is non-uniform. Spatial 
discretization in the VID is shown in figure 1(b). A growth of 
20% has been used from the first layer near the wall, indicating 
that the thickness of consecutive layers is 20% more compared to 
the previous layer. 
2.2.*Solver Settings 
Specifications of appropriate boundary conditions are critical 
to the accuracy of any numerical analysis. In the present study, 
the inlet boundary of the flow domains has been specified as 
velocity inlets, while the outlet boundary has been specified as 
pressure outlet. The inlet velocity of 0.5m/s has been specified at 
each inlet duct of the VID. The outlet boundary condition of the 
flow domain has been specified with 0Pa gauge pressure. The 
walls of the flow domain (such as cyclone separator walls, inlet 
   
!"#$%"&#'("&)*+(,%"&)*(-*./01230*
duct walls, outlet duct walls etc.) have been modelled as no-slip 
boundaries, as expected in real-world. Furthermore, Salbutamol 
droplets have been ejected within the VID at 0.02seconds of the 
running time of impeller, to get it mixed with the air for 
0.04seconds. The density of air and salbutamol is 1.225kg/m
3
 and 
1152kg/m
3
. The size of particles chosen is 0.0032mm, which are 
ejected inside the cyclone separator at the rate of 11.3m/s with 
the impeller rotational speed of 2000rpm. In order to resolve 
turbulence parameters numerically, Shear Stress Transport (SST) 
k-ω turbulence model has been used in the present study [18]. 
This turbulence model comprises of a cross-diffusion term in 
turbulent dissipation rat equation, along-with a blending function, 
to ensure that the model behaves appropriately in both bear-wall 
and far-field zones. Reynolds Averages Navier-Stokes (RANS) 
equations [19-20], along-with the mass conservation and 
turbulence parameters’ equations, have been iteratively solved 
for unsteady flow of air and Salbutamol particles within the VID. 
A convergence criterion of 0.001 for continuity, momentum 
conservation and turbulence parameters has been specified. 
 
(a) 
 
(b) 
Figure 1. (a) Geometry of VID (b) Mesh within VID 
 
3.!Results and Discussions 
The flow field within VID has been depicted in the form of 
pressure and velocity fields. Figure 2(a) depicts the static 
pressure variations within VID. It can be seen that the static 
pressure is higher within the cyclone separator and is lower at 
nose of the impeller and across the outlet duct. The static 
pressure is nearly 30Pa near the tips of the impeller region and 
reduced towards the impeller nose region and the center with a 
pressure drop of around 25Pa. This pressure drop is obtained as 
the cyclone separator has increased the angular momentum of the 
flow, which in-turn has increased the flow velocity. Increase of 
velocity magnitude reduces the static pressure within the cyclone 
separator. 
 
(a) 
 
(b) 
Figure 2. Flow variations within VID (a) Static pressure (Pa) and 
(b) Velocity magnitude (m/s) 
 
Figure 2(b) depicts the velocity magnitude distribution within 
VID. It can be seen that the velocity magnitude is higher within 
the cyclone separator and is lower at nose of the impeller and 
across the outlet duct. The velocity magnitude is nearly 3.5m/s 
within the impeller passages and is higher near the blades due to 
rotational speed of impeller blades. The velocity magnitude is 
increased near the impeller tips region up to 5m/s. Furthermore, 
as the flow ejecting from the cyclone separator have a high 
vorticity, hence causing low velocity magnitude across the center 
and high radial velocity magnitude outwards. 
 
3.1.*Performance Analysis 
To better understand the performance of VID, a systematic 
investigation has been carried out at various flow conditions, and 
at different rotational speeds. The aim here is to obtain the 
performance curves of VID. Design of Experiments (DoE) has 
been employed in the present study to determine the possible 
particle combinations of these parameters as shown in table 1. 
The inlet air velocity of 1m/s, 2m/s, 3m/s, 4m/s, 5m/s and 6m/s 
have been specified at each inlet duct [21] with the impeller 
speed of 1340rpm, 2100rpm and 2620rpm respectively for each 
design point as been carried out by Coates et al. The systematic 
investigation has also been carried out using the flow field within 
VID and has been depicted in the form of pressure and velocity 
fields. 
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Table 1. Factors and levels for full factorial design of diffuser 
configurations 
Factors 
Rotational speed Inlet velocity
(rpm) (m/s) 
Level 1 1340 1 
Level 2 2100 2 
Level 3 2620 3 
Level 4 - 4 
Level 5 - 5 
Level 6 - 6 
Figure 3 depicts static pressure variations within VID at (a) 
inlet velocity of 1m/s (b) inlet velocity of 6m/s at rotational speed 
of 1340rpm respectively, and (c) inlet velocity of 1m/s at 
rotational speed of 2620rpm. It can be seen that the trend 
obtained within the inhaler body is similar to baseline geometry, 
having high static pressure near the impeller tip and the pressure 
drops in the center of the impeller region (impeller nose). 
Similarly, the pressure drops towards the outlet duct. However, 
as the inlet velocity is increased the static pressure is increased 
within the inhaler body as well. Furthermore, it also has been 
observed that by keeping the same velocity inlet of 1m/s but 
higher rotational speed of 2620rpm reduces the static pressure 
within inhaler body, however trend remains similar within the 
inhaler body. 
(a)! (b) 
(c) 
Figure 3. Static pressure (Pa) variations within VID at (a) inlet 
velocity of 1m/s (b) inlet velocity of 6m/s at rotational speed of 
1340rpm respectively, and (c) inlet velocity of 1m/s at rotational 
speed of 2620rpm 
A quantitative analysis has also been carried out whereby the 
pressure coefficient, Cp has been investigated at three different 
design points at (a) inlet velocity of 1m/s (b) inlet velocity of 
6m/s at rotational speed of 1340rpm respectively, and (c) inlet 
velocity of 1m/s at rotational speed of 2620rpm. It can be seen 
that pressure coefficient is higher when the inlet velocity is 
higher by keeping same rotational speed. Furthermore, the 
pressure coefficient drops as the rotational speed is increased by 
keeping the same inlet velocity. Moreover, it has also been 
observed that increasing inlet velocity reduces flow recirculation 
and angular velocity increase causes increase in flow 
recirculation, which could result in particle deposition on the 
inhaler body. 
(a) 
(b) 
Figure 4. Pressure coefficient variations at three design points 
across the line shown in (b) of VID 
Figure 5 depicts velocity magnitude distribution within VID at 
(a) inlet velocity of 1m/s (b) inlet velocity of 6m/s at rotational
speed of 1340rpm respectively, and (c) inlet velocity of 1m/s at
rotational speed of 2620rpm. It can be seen that the trend
obtained within the inhaler body is similar to the baseline
geometry, whereby the velocity magnitude is higher within the
cyclone separator and is lower at nose of the impeller and across
the outlet duct. Furthermore, as the inlet velocity increases at
same rotational speed, the velocity magnitude rises within VID.
However, the trend of the velocity magnitude remains similar.
Moreover, it also has been observed that by keeping the same
velocity inlet of 1m/s but higher rotational speed of 2620rpm
increases the velocity magnitude within inhaler body; however,
trend remains similar within the inhaler body.
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(a)! (b) 
(c) 
Figure 5. Velocity magnitude (m/s) distribution within VID at 
(a) inlet velocity of 1m/s (b) inlet velocity of 6m/s at rotational
speed of 1340rpm (c) inlet velocity of 1m/s at rotational speed of
2620rpm
Figure 6 depicts Salbutamol particle dispersion rate (m/s) 
within VID at (a) inlet velocity of 1m/s (b) inlet velocity of 6m/s 
at rotational speed of 1340rpm respectively, and (c) inlet velocity 
of 1m/s at rotational speed of 2620rpm. It has been observed that 
increased inlet velocity causes particles velocity to increase with 
minimum flow recirculation, which results reduced particle 
deposition within inhaler body but could cause high dosage of 
Salbutamol on the mouth cavity. On the other hand, increased 
rotational velocity at with constant inlet velocity, increases the 
flow recirculation but has reduced flow rate of dosage. This result 
in high deposition rate within the inhaler body but does not have 
strong impact on the dosage. 
4. Conclusions
A detailed investigation on flow variations and particle
distribution has been conducted within VID. A full factorial 
based DoE has been employed in this study to understand the 
effect of variables considered on each other. It has been observed 
that increase of inlet velocity increases static pressure within the 
inhaler body and increase of rotational speed reduces the static 
pressure. Similarly, increase inlet velocity increases velocity 
magnitude within the inhaler body and increase of rotational 
speed also increases the velocity magnitude within VID. 
Moreover, it has been observed that increase of inlet velocity 
reduces the flow recirculation and projects all the flow towards 
the VID outlet. This results in reduced particle deposition within 
the inhaler body but increases the aerosol dosage. On the other 
hand, increased rotational speed increases the flow recirculation 
and hence can cause the particle deposition. A detailed study 
needs to be carried out whereby an optimized sequence of inlet 
velocity and rotational speed has been selected where particle 
deposition is reduced. Furthermore, the effect of particle 
deposition rate has to be quantitatively investigated within the 
VID and its impact on the lungs. 
(a) 
(b) 
(c) 
Figure 6. Salbutamol particle dispersion rate (m/s) within VID at 
(a) inlet velocity of 1m/s (b) inlet velocity of 6m/s at rotational
speed of 1340rpm (c) inlet velocity of 1m/s at rotational speed of
2620rpm
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